Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Preventions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07581808
What this trial is testing

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease (ASCVD)
University Medical Centre Ljubljana 60
Large-scale testing (Phase 3)Study completedNCT02815670
What this trial is testing

Reversal Dabigatran Anticoagulant Effect With Idarucizumab

Who this might be right for
Hemorrhage
Boehringer Ingelheim 1
Not applicableStudy completedNCT04990596
What this trial is testing

Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)

Who this might be right for
Drug Resistance
Rennes University Hospital 37
Not applicableStudy completedNCT04161859
What this trial is testing

Use of Nutraceuticals in Clinical Practice

Who this might be right for
DyslipidemiasDiabetes Mellitus, Type 2Hypertension
University of Pavia 387
Not applicableActive Not RecruitingNCT04582825
What this trial is testing

Stroke-Card Registry

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
VASCage GmbH 5,000
Not applicableStudy completedNCT00145067
What this trial is testing

Osteoporosis Disease Management Demonstration Project (0000-040)

Who this might be right for
Osteoporosis
Merck Sharp & Dohme LLC 230
Large-scale testing (Phase 3)Study completedNCT00124371
What this trial is testing

Programme to Optimise Risk Factors in Patients Waiting for Coronary Artery Bypass Surgery

Who this might be right for
Coronary Artery Disease
Royal Brompton & Harefield NHS Foundation Trust 200
Not applicableActive Not RecruitingNCT06701032
What this trial is testing

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

Who this might be right for
Peripheral Artery Disease (PAD)Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Cerebrovascular Atherosclerosis
Laval University 80
Not applicableStudy completedNCT01779999
What this trial is testing

Early Detection of PICC-related Deep Vein Thrombosis by US Surveillance: an Effective Approach for Secondary Prevention?

Who this might be right for
Central Venous Catheter Thrombosis
University of Turin, Italy 150
Not applicableStudy completedNCT07761130
What this trial is testing

A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)

Who this might be right for
Stroke
University of Limerick 19
Post-approval studies (Phase 4)Not Yet RecruitingNCT07795398
What this trial is testing

DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease

Who this might be right for
Ischemic Heart DiseaseIschemic Heart Disease ChronicChronic Coronary Syndrome+6 more
Odense University Hospital 7,000
Not applicableLooking for participantsNCT04775160
What this trial is testing

Smartphone-based Ecological Momentary Intervention for Suicide Prevention: a Randomised Clinical Trial

Who this might be right for
Suicide
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 220
Post-approval studies (Phase 4)UnknownNCT00724724
What this trial is testing

The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial

Who this might be right for
StrokeTransient Ischemic Attack
Peking Union Medical College Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT00617123
What this trial is testing

Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)

Who this might be right for
AtherosclerosisIschemiaMyocardial Infarction+1 more
Merck Sharp & Dohme LLC 258
Not applicableNot Yet RecruitingNCT07640360
What this trial is testing

Smartwatch-Guided Secondary Prevention After Stroke

Who this might be right for
StrokeTransient Ischemic Attack
University Hospital, Brest 50
Testing effectiveness (Phase 2)Looking for participantsNCT06926751
What this trial is testing

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Who this might be right for
Solid TumorsChildrenAdolescent+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 132
Not applicableStudy completedNCT03185858
What this trial is testing

SINEMA Model of Care to Improve the Health of Stroke Patients in Rural China

Who this might be right for
Stroke
Duke Kunshan University 1,299
Not applicableNot Yet RecruitingNCT07098143
What this trial is testing

An Application Provides Personalized Suggestions Based on Secondary Prevention Risk Factors to Stroke Patients

Who this might be right for
Acute Ischemic Stroke
Xuanwu Hospital, Beijing 5,092
Not applicableLooking for participantsNCT06701968
What this trial is testing

Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease

Who this might be right for
Coronary DiseaseCoronary ArteriosclerosisMyocardial Infarction+3 more
Uppsala University 150
Not applicableStudy completedNCT01115608
What this trial is testing

Pharmaceutical Follow-up of Coronary Heart Disease (CHD) Patients

Who this might be right for
Coronary Heart Disease
Hospital Pharmacy of North Norway Trust 102
Next Page